Internal medicine full syllabus and strategy
NEXT exam India internal medicine syllabus 2024 2025
NEXT India NExT exam internal medicine high yield topics strategy
https://www.diginerve.com/blogs/next-exam-pattern
| Feature | Detail |
|---|---|
| Exam | National Exit Test (NExT) |
| Step 1 | Theory - MCQs (before internship) |
| Step 2 | Clinical/Practical (after internship) |
| Focus | CBME - clinical application, NOT pure recall |
| Replaces | NEET PG + FMGE |
| Pattern | Application-based, integrated, clinically oriented |
| Topic | Key Areas |
|---|---|
| Ischemic Heart Disease | ACS (STEMI/NSTEMI/UA), management algorithms, thrombolytics vs PCI, TIMI score |
| Heart Failure | HFrEF vs HFpEF, NYHA classification, drugs (ARNI, SGLT2i, BB, ACEi), acute pulmonary edema management |
| Hypertension | JNC 8 / ISH guidelines, resistant HTN, hypertensive emergencies, drug of choice in specific conditions |
| Arrhythmias | AF management (rate vs rhythm control, anticoagulation - CHA2DS2-VASc), VT/VF, complete heart block |
| Valvular Heart Disease | Mitral stenosis (most common RHD in India), MS area classification, surgical indications |
| Infective Endocarditis | Duke criteria, organisms, antibiotic prophylaxis |
| Pericardial Disease | Pericarditis, tamponade (Beck's triad), constrictive pericarditis |
| Aortic Dissection | DeBakey / Stanford classification, management |
| Peripheral Vascular Disease | ABI, critical limb ischemia |
| Topic | Key Areas |
|---|---|
| COPD | GOLD staging, exacerbation management, bronchodilators (LABA/LAMA), NIV criteria |
| Asthma | GINA stepwise therapy, status asthmaticus, severity classification |
| Pneumonia | CAP vs HAP vs VAP, CURB-65, organisms by setting, antibiotic choice |
| Tuberculosis | RNTCP/NTEP regimen (2HRZE/4HR), drug resistance (MDR/XDR-TB), DOTS, DRTB drugs |
| Pleural Effusion | Light's criteria (exudate vs transudate), causes, investigation |
| Pulmonary Thromboembolism | Wells score, D-dimer, CTPA, anticoagulation (DOAC vs heparin) |
| Interstitial Lung Disease | UIP (IPF), NSIP, sarcoidosis |
| Lung Cancer | Types, paraneoplastic syndromes, Lambert-Eaton, SIADH |
| Sleep Apnea | OSA - CPAP indications, Epworth scale |
| Pneumothorax | Spontaneous vs secondary, management |
| Topic | Key Areas |
|---|---|
| Peptic Ulcer Disease | H. pylori eradication, NSAID-induced, complications |
| GERD | Diagnosis, PPI use, Barrett's esophagus |
| Liver Disease | Child-Pugh / MELD score, cirrhosis complications (ascites, SBP, HRS, HE, variceal bleed) |
| Hepatitis | Viral hepatitis (A/B/C/D/E) - serology interpretation, treatment (HBV - tenofovir; HCV - sofosbuvir-based) |
| Inflammatory Bowel Disease | UC vs Crohn's - differences, extraintestinal manifestations, treatment |
| Pancreatitis | Ranson's criteria, Atlanta classification, management |
| GI Bleeding | Upper vs lower, causes, management |
| Malabsorption | Celiac disease (anti-tTG, HLA-DQ2/DQ8), tropical sprue |
| Jaundice | Pre-hepatic/hepatic/post-hepatic workup |
| Colorectal Cancer | Screening, FAP, Lynch syndrome |
| Topic | Key Areas |
|---|---|
| AKI | KDIGO staging, causes (pre/intra/post-renal), management, indications for dialysis (AEIOU) |
| CKD | GFR staging, complications, anemia of CKD, renal osteodystrophy, preparation for RRT |
| Glomerulonephritis | Nephrotic vs nephritic syndrome - diseases in each, cause-specific treatment |
| Nephrotic Syndrome | MCD (children - steroids), FSGS, membranous nephropathy (PLA2R antibody), DM nephropathy |
| Nephritic Syndrome | Post-streptococcal GN, IgA nephropathy (Berger's disease), RPGN |
| Hypertensive Nephropathy | |
| Tubular Disorders | RTA types (1,2,4), Fanconi syndrome |
| Renal Calculi | Types, investigation (NCCT), metabolic workup, management |
| Electrolyte Disorders | Hypo/hypernatremia, hypo/hyperkalemia, calcium, phosphate, magnesium |
| Dialysis | HD vs PD, indications |
| Topic | Key Areas |
|---|---|
| Diabetes Mellitus | T1 vs T2, diagnostic criteria, HbA1c targets, insulin types, OHA mechanisms (SGLT2i, GLP-1 RA, DPP4i), complications |
| Diabetic Emergencies | DKA vs HHS - differences, management |
| Thyroid Disorders | Hypothyroidism (TSH targets), hyperthyroidism (Graves' - TRAb, treatment), thyroid crisis, sick euthyroid |
| Thyroid Nodule/Cancer | FNAC, Bethesda system, papillary (most common) |
| Adrenal Disorders | Cushing's syndrome (workup - UFC, LDDST, HDDST), Addison's disease, Conn's syndrome (primary hyperaldosteronism), pheochromocytoma |
| Pituitary | Acromegaly (IGF-1, OGTT suppression), prolactinoma (dopamine agonist), Sheehan's syndrome, DI |
| Calcium Disorders | Primary hyperPTH, hypoparathyroidism, osteoporosis (DEXA, T-score) |
| Metabolic Syndrome | IDF/ATP III criteria |
| Obesity | BMI classification, management |
| PCOS | Rotterdam criteria, treatment |
| Topic | Key Areas |
|---|---|
| Anemias | Iron deficiency (Mentzer index), B12/folate deficiency, hemolytic anemias (Coombs test), aplastic anemia |
| Hemolytic Anemias | G6PD deficiency, hereditary spherocytosis, PNH, AIHA, sickle cell |
| Thalassemia | Alpha vs beta thal, management, prenatal diagnosis |
| Coagulation Disorders | Hemophilia A/B, vWD (types), DIC (lab pattern), ITP vs TTP |
| Transfusion Medicine | Compatibility, reactions (hemolytic, febrile, anaphylactic), massive transfusion |
| Leukemias | ALL vs AML vs CLL vs CML - key features, Philadelphia chromosome, BCR-ABL, imatinib |
| Lymphomas | Hodgkin's (Reed-Sternberg, ABVD) vs Non-Hodgkin's |
| Myeloma | Diagnostic criteria (CRAB), M-spike, bone lesions |
| Myeloproliferative Disorders | PV, ET, MF - JAK2 mutation |
| Thrombophilia | Factor V Leiden, APS (criteria, treatment) |
| Topic | Key Areas |
|---|---|
| Stroke | Ischemic vs hemorrhagic, thrombolysis (tPA - 4.5 hour window, contraindications), NIHSS |
| Epilepsy | Seizure classification, drug of choice by seizure type, status epilepticus management |
| Headache | Migraine (triptans), cluster headache, tension-type |
| Dementia | Alzheimer's (most common), Lewy body, FTD, vascular - features |
| Movement Disorders | Parkinson's disease (dopaminergic therapy, TRAP), essential tremor |
| Multiple Sclerosis | Relapsing-remitting, McDonald criteria, DMDs |
| Meningitis | Bacterial vs viral - CSF findings, empiric treatment |
| Peripheral Neuropathy | GBS (cytoalbuminous dissociation), Charcot-Marie-Tooth, mononeuritis multiplex |
| Neuromuscular | MG (anti-AChR, Tensilon test, thymoma), Lambert-Eaton |
| CNS Infections | Tuberculous meningitis (ADA in CSF), neurocysticercosis, cerebral malaria |
| Topic | Key Areas |
|---|---|
| Malaria | P. falciparum (severe malaria criteria - WHO 2015), treatment (ACT), chloroquine resistance |
| Typhoid | Widal (limitations), culture gold standard, drug of choice (azithromycin/ciprofloxacin), complications |
| Dengue | NS1/IgM, warning signs, management (no platelet <10k), grades |
| Leptospirosis | Weil's disease, conjunctival suffusion, penicillin |
| Kala-azar (VL) | rK39, splenomegaly, treatment (liposomal AmB) |
| Scrub Typhus | Eschar, Orientia, doxycycline |
| HIV/AIDS | CD4 staging, ART (NACO guidelines - TLD regimen), OIs by CD4 count |
| COVID-19 | Complications, management principles |
| Meningococcemia | Waterhouse-Friderichsen |
| Rickettsial Diseases | Rocky Mountain spotted fever, doxycycline |
| Topic | Key Areas |
|---|---|
| Rheumatoid Arthritis | ACR/EULAR criteria, DMARD choice (MTX first line), biologic agents |
| SLE | ACR criteria, ANA/anti-dsDNA/anti-Sm, lupus nephritis, SLEDAI |
| Seronegative SpA | AS (HLA-B27), PsA, ReA, IBD-related - differences |
| Crystal Arthropathies | Gout (urate-lowering: allopurinol/febuxostat), pseudogout (CPPD) |
| Vasculitides | GCA (temporal artery biopsy, ESR), Takayasu, PAN (HBV-assoc.), Wegener's/GPA (c-ANCA) |
| Scleroderma | Limited (CREST, anti-centromere) vs diffuse (anti-Scl-70), SSc lung |
| Myositis | PM/DM - anti-Jo-1, proximal weakness, skin findings in DM |
| Antiphospholipid Syndrome | Recurrent thrombosis/miscarriage, lupus anticoagulant |
| Sjögren's | Anti-SSA/SSB, sicca syndrome |
| Topic | Key Areas |
|---|---|
| Systemic disease skin manifestations | Acanthosis nigricans (IR/DM), pyoderma gangrenosum (IBD), erythema nodosum |
| Drug rashes | SJS/TEN (causes: sulfa, allopurinol, AEDs), DRESS syndrome |
| Autoimmune skin | Pemphigus vs pemphigoid |
| Topic |
|---|
| Sepsis (Sepsis-3 criteria, qSOFA, SOFA) |
| ARDS (Berlin criteria, P/F ratio, prone positioning) |
| Mechanical ventilation basics |
| Shock types (distributive/cardiogenic/hypovolemic/obstructive) |
| Poisoning (organophosphate, paracetamol, iron, CO) |
| Electrolyte emergencies |
| Priority | Topics |
|---|---|
| MUST DO | Cardiology (ACS/HF/HTN), Diabetes + thyroid, Hepatitis + cirrhosis, TB (NTEP), HIV (NACO), AKI/CKD, Anemia types, Dengue/malaria/typhoid, Stroke |
| HIGH YIELD | Nephrotic/nephritic syndrome, COPD/Asthma, SLE, Leukemia/lymphoma, GBS, Hemophilia, Sepsis |
| MODERATE | IBD, Vasculitis, Interstitial lung disease, Pituitary disorders, Myeloma, Parkinson's |
| LOW YIELD (do last) | Rare metabolic disorders, esoteric enzyme deficiencies, individual drug pharmacokinetics |
| Purpose | Book |
|---|---|
| Primary theory | Davidson's Medicine (26th ed) OR Harrison's (selected chapters) |
| Quick revision | APICP Manual of Medicine OR Medicine Recall |
| MCQ practice | DAMS previous papers + Marrow/Prepladder Qbank |
| Notes/Mnemonics | Own notes + Rohan Khandelwal's IM notes |
| ECG | ECG Made Easy by John Hampton |
| Images | Sobotta Atlas + CBT image gallery |
| Day | Morning (3h) | Evening (2h) | Night (1.5h) |
|---|---|---|---|
| Mon | Theory reading (new topic) | MCQ practice (same topic) | Revision of yesterday |
| Tue | Theory reading | MCQ practice | Previous year Qs |
| Wed | Theory reading | MCQ practice | Short notes making |
| Thu | Revision (weak areas) | MCQ practice | Integration questions |
| Fri | New topic | MCQ practice | Tables/comparisons |
| Sat | Full-length mock test | Test analysis | Error correction |
| Sun | Weak area deep dive | Light MCQs | Weekly notes review |